Amoxicillin Clavulanate Manufacturer in India: Complete 2026 Guide

Amoxicillin plus clavulanate is one of those product categories where a low quotation can look attractive for about five minutes.

Then the real questions start. Does the factory hold permission for your exact strength? Is it equipped to manufacture the dosage form you want? Who checks assay and dissolution? Is the blister material included? What happens if the printed foil supplier asks for four times your finished-product MOQ?

If you’re searching for an amoxicillin clavulanate manufacturer, you are probably not looking for a textbook explanation of the antibiotic. You need a reliable production partner. You need numbers. And you need a checklist that reduces the risk of blocked capital, delayed dispatch or a batch that doesn’t match the approved specification.

India’s pharmaceutical market is estimated at ₹5,20,000 crore in 2026, according to IBEF, which reflects the scale of the country’s manufacturing ecosystem. Baddi, Solan, Paonta Sahib, Haridwar, Ahmedabad, Sikkim and nearby commercial hubs such as Zirakpur and Ambala all appear regularly in sourcing discussions.

This guide explains product formats, MOQ, commercial cost heads, quality checks, licences, the seven-step order process and manufacturer verification. It is written for PCD owners, pharma marketers and entrepreneurs who are about to spend real money.

What Is Amoxicillin Clavulanate Third Party Manufacturing?

Amoxicillin clavulanate third party manufacturing is an arrangement where a licensed pharmaceutical plant produces an approved amoxicillin and clavulanic acid fixed-dose combination under another company’s brand and agreed specification.

You provide or approve the brand name, strength, dosage form, pack, artwork, quantity and commercial terms. The factory handles manufacturing, in-process controls, finished-product testing, packing and batch release under its quality system.

CDSCO continues to publish approval records for amoxicillin plus clavulanate combinations. For example, a 600 mg amoxicillin plus 42.9 mg clavulanic acid powder-for-suspension presentation was recorded in 2024, while another 600 mg plus 42.9 mg orodispersible tablet presentation appeared in a 2025 approval record. That matters because product permission is strength-specific and dosage-form-specific. A factory making one combination doesn’t automatically have approval for every combination.

For broader sourcing context, see The Pharma Project’s pharma third party manufacturing resource hub. And if your sales model uses regional monopoly rights, this guide explains how PCD pharma franchise works.

Why Does Choosing the Right Amoxicillin Clavulanate Manufacturer Matter in 2026?

The right manufacturer matters because antibiotic quality, documentation and supply consistency cannot be repaired with better marketing after the batch reaches the market.

The Indian pharmaceutical market is estimated at ₹5,20,000 crore in 2026 by IBEF, up from ₹4,97,000 crore in 2025. Scale creates opportunity. It also creates a crowded supplier market where genuine manufacturers, loan-licence arrangements, contract marketers and trading companies can all appear in the same search result.

So what exactly are you buying?

You are not just buying tablets or bottles. You are buying a manufacturing system. The WHO describes GMP as the quality-assurance framework that ensures medicinal products are consistently produced and controlled according to the standards appropriate to their intended use. It also covers contract manufacturing, testing, complaints and product defects.

That is particularly relevant for antibiotics. You need tight control over raw materials, batch records, cross-contamination risks, packing and release. A product can look perfect and still fail a quality parameter that the eye cannot see.

And a delay is not harmless either. A PCD marketer may already have sales commitments, visual aids, promotional material and distributors waiting. A 20-day production delay can push a seasonal sales cycle out of alignment.

Which Amoxicillin Clavulanate Product Formats Can You Source?

Amoxicillin plus clavulanate can be sourced in multiple approved strengths and dosage forms, but you must match your order to the manufacturer’s exact permission and production capability.

Don’t ask a general tablet manufacturer to “arrange” an injectable just because both products contain the same active ingredients. Sterile manufacturing needs a completely different facility and control system.

Also, don’t assume every strength you see in the market can be freely produced by any plant. The actual product permission matters. For broader medicine classification context, the site’s Schedule H prescription drugs guide is useful, while the existing amoxicillin information article covers consumer-facing medicine information separately.

What MOQ and Manufacturing Cost Should You Expect?

A practical MOQ often begins near 500 to 2,000 boxes for standard oral products, but the real commercial minimum depends on batch size, pack configuration, printed materials and raw-material planning.

These are planning ranges, not official government fees or fixed market rates. Antibiotic raw-material prices move. So do foil, cartons, bottles and transport.

Suppose Manufacturer A quotes ₹286 per box. Manufacturer B quotes ₹301. At first glance, A wins. But A adds ₹18,500 for printing setup, charges freight separately and requires you to buy 3,000 cartons even though your finished order is 1,000 boxes. B includes those items.

Now which quotation is cheaper?

From my work with manufacturing companies around Zirakpur and the Baddi belt, one pattern appears again and again. First-time buyers focus heavily on the per-box price, while experienced marketers ask about leftover printed material, dispatch timing and batch documents before negotiating the last ₹2 or ₹3. That small change in questioning prevents a surprising number of disputes.

Which Licences and Documents Should You Verify Before Ordering?

You should verify the manufacturing licence, exact product permission, GMP or applicable Schedule M evidence, legal entity details, quality documents and manufacturing agreement before releasing a commercial order.

• Manufacturing licence: Match the legal name, address, licence number and validity with the actual factory.
• Product permission: Confirm the exact amoxicillin plus clavulanate strength and dosage form.
• GMP / Schedule M evidence: Check current status and scope rather than accepting a logo printed on a catalogue.
• GST and PAN: Make sure the quotation, invoice entity and bank beneficiary make sense together.
• Approved composition: Freeze the amoxicillin and clavulanic-acid equivalents in writing.
• Artwork approval: Confirm prescription warnings, manufacturer details, marketer details, MRP, batch coding area and pack information.
• Sample COA: Review what the factory reports on a finished batch.
• Supply agreement: Define batch rejection, shortage, complaint, recall, leftover packaging and replacement responsibility.

The official CDSCO website publishes central drug approvals, rules, notices and FDC information. CDSCO’s current approval pages also show ongoing approvals involving amoxicillin plus clavulanate combinations.

If the supplier sends you a licence in one company name but asks you to pay another unrelated entity, stop and ask why. There may be a legitimate commercial structure, but it should be documented.

And don’t confuse food or Ayurvedic permissions with drug manufacturing permissions. FSSAI and AYUSH regulate different product categories. An antibiotic combination sits inside the pharmaceutical regulatory framework.

Which Quality Checks Matter for Amoxicillin Clavulanate Products?

Quality checks should cover identity, strength, uniformity, release performance, degradation-related parameters, physical quality and packaging integrity according to the approved specification.

The WHO GMP guidance explains that GMP is designed to minimise production risks that finished-product testing alone cannot remove. WHO also specifically includes contract manufacturing, testing, complaints and product defects within GMP responsibilities.

For dry syrup, pay close attention to moisture protection, bottle closure and reconstitution-related specifications. For tablets, pack barrier properties matter. A strong formula inside a weak pack is still a weak commercial product.

How Do You Verify an Amoxicillin Clavulanate Manufacturer?

You verify a manufacturer by checking the real factory, licence, product permission, beta-lactam capability, quality records, samples, commercial terms and communication discipline.

1. Confirm the actual manufacturing site. Ask exactly where your batch will be produced and packed.
2. Check the licence. Match the factory name and address with the document.
3. Match product permission. The exact strength and dosage form should be covered.
4. Ask about beta-lactam controls. The technical team should explain segregation and contamination-control practices relevant to the facility.
5. Request samples. Check tablet or dry-syrup presentation, print quality, sealing and carton finish.
6. Review a redacted COA. Ask the QA or QC team to explain the main quality parameters.
7. Check lead-time honesty. “Seven days for everything” is usually not a serious answer for a new printed commercial batch.
8. Ask about complaints. What happens if there is shortage, leakage, pack failure or a confirmed quality defect?

If you are comparing specialised production environments, the site’s page on an MDI manufacturer in Baddi shows why dosage-form capability must be treated separately rather than assuming one plant can make every medicine.

Export-focused buyers should also use The Pharma Project’s pharma export resources and official Pharmexcil information to build a destination-specific document checklist.

What Is the 7-Step Amoxicillin Clavulanate Manufacturing Process?

The commercial process moves from a precise product brief to screening, documentation, sample approval, commercial confirmation, batch production and final dispatch.

You can get a free manufacturing quote by sending the required strength, dosage form, pack and commercial quantity.

Which Mistakes Cost Buyers the Most Money?

The most expensive mistakes are choosing only by rate, ignoring exact product permission, printing too early, missing packaging MOQ and relying on verbal commitments.

1. Treating Every “Manufacturer” as the Factory

A supplier may be a marketer coordinating production elsewhere. That isn’t automatically wrong. But you need to know the legal arrangement, actual plant and licence holder.

2. Assuming One Permission Covers Every Strength

It doesn’t. Strength, dosage form and approved fixed-dose combination matter. Check the exact product.

3. Printing Thousands of Cartons Before Final Review

One wrong composition line, address or mandatory warning can turn ₹38,000 worth of packaging into waste.

4. Ignoring Leftover Printed Material

Your finished MOQ might be 1,000 boxes while the foil or carton printer requires much more. Decide who owns and stores the balance before production.

5. Paying for Speed Instead of Planning

If your launch date is important, start the artwork and document review early. Emergency production is usually more expensive and still cannot bypass required quality release.

6. Using Only the Sample to Judge Quality

A sample tells you how the product looks. It doesn’t prove the commercial batch will be made at the claimed site under the promised controls. Documents still matter.

Conclusion: Choose the Plant Before You Choose the Price

An amoxicillin clavulanate manufacturer should be selected on three things before anything else: legal permission for the exact product, a credible quality system and commercial reliability. Once those are clear, compare MOQ and landed cost.

Don’t let a ₹2 or ₹3 rate difference distract you from a 25-day dispatch delay, a packaging mismatch or weak documentation. Check the real manufacturing site. Review the product permission. Ask who releases the batch and what happens if a complaint is confirmed.

A standard order may start near 500 to 2,000 boxes and may take roughly 35 to 55 days if the product and packaging are already established. New permissions or custom packs take longer.

Start with a controlled batch, keep every approval in writing and retain one sealed market sample. Your name is on the pack. The manufacturer’s consistency becomes part of your reputation.